Heidi Finnes News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Heidi Finnes. Real-time updates on events, politics, business and more.

INDIGO Trial Provides First Randomized Data Supporting Use of IDH Inhibitor in Patients With IDH1/2 Mutating Gliomas

June 18, 2023

Heidi Finnes, PharmD, BCOP, FHOPA, addresses how the study data may impact the treatment of IDH1/2 mutating gliomas going forward.

United States Heidi Finnes Leadiant Biosciences Clinical Ambulatory Pharmacy Practice Mayo Clinic Pharmacists Connect

Source: pharmacytimes.com

Expert: Immunotherapies, Targeted Therapies Show Promise in Melanoma

June 16, 2023

Heidi Finnes, PharmD, BCOP, FHOPA, director of clinical ambulatory pharmacy practice at Mayo Clinic, discussed updates in melanoma and the use of immunotherapies and targeted therapies.

United States Heidi Finnes Pharmacy Times Oncology Pharmacists Connect Mayo Clinic

Source: pharmacytimes.com

HOPA President Brings Expertise and Unique Perspective to Hematology/Oncology Pharmacy Practice

April 8, 2022

Milwaukee, WI (PRWEB) April 08, 2022 -- Heidi D. Finnes, PharmD, BCOP, FHOPA became President of the Hematology/Oncology Pharmacy Association (HOPA) on April

United States Heidid Finnes Pharmd Heidid Finnes Heidi Finnes Mayo Clinic College Of Medicine Mayo Clinic Cancer Center

Source: prweb.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Heidi Finnes News Today

INDIGO Trial Provides First Randomized Data Supporting Use of IDH Inhibitor in Patients With IDH1/2 Mutating Gliomas

Expert: Immunotherapies, Targeted Therapies Show Promise in Melanoma

HOPA President Brings Expertise and Unique Perspective to Hematology/Oncology Pharmacy Practice

Explore More Categories